This is a competing renewal for the Penn Center for AIDS Research (CFAR), which includes the University of Pennsylvania, The Children's Hospital of Philadelphia and The Wistar Institute. This CFAR links faculty engaged in HIV/AIDS research at these three institutions under a single administrative structure that is committed to goals laid out in the NIH CFAR mission statement and in particular to fostering interdisciplinary HIV/AIDS research activities among its members. Members include over 115-faculty from multiple Schools, Departments and Institutes located on the Penn campus. The primary goals of the Penn-CFAR are 1) to create an infrastructure that facilitates communication, collaboration and synergy among AIDS/HIV researchers; 2) to establish shared resource Core facilities that enhance the overall research environment and promote interdisciplinary research; 3) to develop programs in community outreach and AIDS education for students and faculty; 4) to develop community outreach efforts that address the problems of HIV/AIDS in domestic and international populations most affected by the epidemic; and 5) to facilitate recruitment of new faculty and the development of resources to build clinical, basic and behavioral science programs that are at the forefront of HIV/AIDS research. The Penn-CFAR includes four scientific programs: Pathogenesis, Clinical/Therapeutics, Immunology/Vaccine, and Behavioral & Social Sciences. The Center is directed by Dr. James A. Hoxie and co-directed by Dr. Francisco Gonzalez-Scarano and is governed by an Executive Committee whose membership includes senior scientists from the four programs (Drs. Linda Aiken, Ronald Collman, Robert Doms, Terri Finkel, Harvey Friedman, David Metzger, and James Wilson). The CFAR supports an Administrative Core, a Developmental Core, and seven shared resource Cores that include a Clinical, Virus/Cell/Molecular, Immunology, Behavioral and Social Sciences, and a Biostatistics & Data Management Core, and for the next funding period, two new Cores, a Non-Human Primate Core based at Tulane National Primate Research Center and an International Core focusing on ongoing initiatives in Botswana and Malawi. This renewal will build on the successes and strengths of the Penn-CFAR's first five years. The Center remains committed to developing a creative, comprehensive, and interdisciplinary AIDS research program that is fully integrated with the research and educational mission of the University and dedicated to meeting the challenges posed by the AIDS pandemic.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-08
Application #
7088917
Study Section
Special Emphasis Panel (ZAI1-AR-A (J3))
Program Officer
Young, Janet M
Project Start
1999-07-01
Project End
2009-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
8
Fiscal Year
2006
Total Cost
$2,540,136
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Abdel-Mohsen, Mohamed; Kuri-Cervantes, Leticia; Grau-Exposito, Judith et al. (2018) CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med 10:
Barbian, Hannah J; Li, Yingying; Ramirez, Miguel et al. (2018) Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees. Am J Primatol 80:
Ke, Ruian; Li, Hui; Wang, Shuyi et al. (2018) Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence. Proc Natl Acad Sci U S A 115:E7139-E7148
Park, Yoon-Dong; Jarvis, Joseph N; Hu, Guowu et al. (2018) Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence. MBio 9:
MacBrayne, Christine E; Marks, Kristen M; Fierer, Daniel S et al. (2018) Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. J Antimicrob Chemother 73:2112-2119
Veenhuis, Rebecca T; Kwaa, Abena K; Garliss, Caroline C et al. (2018) Long-term remission despite clonal expansion of replication-competent HIV-1 isolates. JCI Insight 3:
Ecker, Christopher; Guo, Lili; Voicu, Stefana et al. (2018) Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments. Cell Rep 23:741-755
Schnoll, Robert A; Thompson, Morgan; Serrano, Katrina et al. (2018) Rate of Nicotine Metabolism and Tobacco Use among Persons with HIV: Implications for Treatment and Research. J Acquir Immune Defic Syndr :
Loy, Dorothy E; Rubel, Meagan A; Avitto, Alexa N et al. (2018) Investigating zoonotic infection barriers to ape Plasmodium parasites using faecal DNA analysis. Int J Parasitol 48:531-542
Kendall, Jacob; Anglewicz, Philip (2018) Migration and health at older age in rural Malawi. Glob Public Health 13:1520-1532

Showing the most recent 10 out of 775 publications